Tonix Pharmaceuticals Hol...
(TNXP) ✕
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
undefined
undefined%
At close: undefined
0.31
-1.54%
Pre-market Jan 07, 2025, 05:08 AM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 |
PE Ratio | -0.06 | -0.12 | -1.41 | -1.22 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -453.7 | -14.80K | -8.50K | -12.42K |
PS Ratio | 0.88 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.07 | 0.07 | 0.60 | 0.73 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -641.59 | -46.19K | 21.79K | 6.12K |
P/FCF Ratio | -0.06 | -0.1 | -1.18 | -1.12 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -596.3 | -14.59K | -9.42K | -11.13K |
P/OCF Ratio | -0.07 | -0.15 | -1.73 | -1.31 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -596.92 | -14.59K | -9.42K | -11.13K |
OCF/S Ratio | -13.13 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.08 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.04 | n/a | -0.85 | n/a | n/a | n/a |
Quick Ratio | 1.78 | 7.64 | 9.06 | 9.74 | 2.91 | 9.81 | 12.44 | 12.83 | 6.97 | 11.54 | 3.90 | 1.77 | 0.16 | 0.45 | 13.19 | 15.30 |
Current Ratio | 2.53 | 7.19 | 8.71 | 8.96 | 2.72 | 9.81 | 12.44 | 12.83 | 6.97 | 11.54 | 3.90 | 1.77 | 0.16 | 0.45 | 13.19 | 15.30 |
Asset Turnover | 0.05 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.72K | -4.13 | n/a | n/a | n/a | n/a |
Return on Equity (ROE) | -1.11 | -0.56 | -0.42 | -0.6 | -3.3 | -1.24 | -0.86 | -1.53 | -1.19 | -0.77 | -1.67 | -0.01 | 1.41 | 3.12 | -2.56 | -0.49 |
Return on Assets (ROA) | -0.76 | -0.52 | -0.38 | -0.53 | -2.14 | -1.12 | -0.79 | -1.41 | -1.02 | -0.7 | -1.25 | -0.00 | -8.16 | -3.83 | -2.37 | -0.46 |
Return on Capital (ROIC) | -0.87 | -0.54 | -0.42 | -0.57 | -3.06 | -1.11 | -0.86 | -1.53 | -1.19 | -0.76 | -1.67 | -6.81 | 6.76 | 3.12 | -2.56 | -0.49 |
Dividend Yield | n/a | 0.47 | n/a | 0.01 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | -0.06 | n/a | -0.01 | -0.08 | -0.11 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 38.97% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | -1.50K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | -1.50K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | -1.52K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | -1.41K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | -1.47K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |